XPO1 was upregulated following RB1/p53 inactivation in human lung and prostate adenocarcinoma cell lines, which was likely through transcriptional regulation via p53 and E2F1, placing XPO1 directly downstream of RB1/p53 loss [56]. Here, TP53 is linked to prostate adenocarcinoma.